Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biologix Hair is a regenerative medicine company focused on the development and commercialization of growth factor-based therapies for hair restoration. Based in Miami, Florida, the company provides non-surgical alternatives to traditional hair transplants through its proprietary Biologix Hair Growth Factor Treatment. This system utilizes a concentrated complex of proteins, cytokines, and naturally occurring growth factors to rejuvenate dormant hair follicles and stimulate new growth. The company's technology is primarily marketed to and utilized by specialized aesthetic and hair restoration clinics. Biologix Hair operates as a key component of the regenerative medicine portfolio developed by Dr. Joseph Greco, a recognized pioneer in the application of biologics for scalp and hair health. Their treatments are specifically formulated to provide high protein concentrations intended for physician-led hair regrowth protocols.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biologix Hair.